BG
Bellevue Group Portfolio holdings
AUM
$5.28B
1-Year Est. Return
50.12%
This Fund
S&P 500
1 Year Est. Return
+50.12%
AUM
$5.28B
AUM Growth
+$464M
(+9.6%)
Holding
185
Top Buys
| 1 | +$120M | |
| 2 | +$105M | |
| 3 | +$102M | |
| 4 |
Krystal Biotech
KRYS
|
+$86.1M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$75.6M |
Top Sells
| 1 | +$149M | |
| 2 | +$139M | |
| 3 | +$113M | |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$109M |
| 5 |
argenx
ARGX
|
+$72.3M |
Sector Composition
| 1 | Healthcare | 99.71% |
| 2 | Technology | 0.1% |
| 3 | Consumer Discretionary | 0.05% |
| 4 | Financials | 0.03% |
| 5 | Communication Services | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$19.6B
| $399M | 7.56% |
5,005,719
-568,119
|
|
||
|
2
argenx
ARGX
$46.8B
| $388M | 7.36% |
461,854
-84,474
|
|
||
|
3
Ionis Pharmaceuticals
IONS
$13.1B
| $380M | 7.2% |
4,802,199
-1,442,252
|
|
||
|
4
Vertex Pharmaceuticals
VRTX
$123B
| $309M | 5.85% |
681,120
+175,315
|
|
||
5
Neurocrine Biosciences
NBIX
$13.3B
| $242M | 4.58% |
1,703,304
-59,801
|
|
||
|
RNAM
6
DELISTED
Avidity Biosciences
RNAM
| $190M | 3.6% |
2,630,969
+478,107
|
|
||
7
Intuitive Surgical
ISRG
$176B
| $182M | 3.46% |
322,028
-26,598
|
|
||
8
Scholar Rock
SRRK
$4.44B
| $179M | 3.39% |
4,056,592
+812,055
|
|
||
9
Alnylam Pharmaceuticals
ALNY
$44.2B
| $177M | 3.36% |
445,903
-621
|
|
||
10
Abbott
ABT
$198B
| $165M | 3.13% |
1,316,915
-161,648
|
|
||
11
Amicus Therapeutics
FOLD
$4.5B
| $153M | 2.9% |
+10,735,195
|
|
||
12
Boston Scientific
BSX
$113B
| $149M | 2.82% |
1,559,606
-100,243
|
|
||
13
Viridian Therapeutics
VRDN
$2.89B
| $136M | 2.57% |
+4,358,527
|
|
||
14
Stryker
SYK
$148B
| $127M | 2.4% |
360,577
-90,519
|
|
||
15
Nuvalent
NUVL
$7.92B
| $104M | 1.98% |
+1,037,468
|
|
||
|
16
Krystal Biotech
KRYS
$8.06B
| $101M | 1.92% |
410,323
+409,011
|
|
||
17
Celldex Therapeutics
CLDX
$2B
| $98.3M | 1.86% |
3,617,669
+60,000
|
|
||
18
Immunocore
IMCR
$1.64B
| $97.1M | 1.84% |
2,796,803
|
|
||
19
Edwards Lifesciences
EW
$50.2B
| $88.9M | 1.69% |
1,043,096
+146,463
|
|
||
20
Vera Therapeutics
VERA
$2.87B
| $86M | 1.63% |
+1,698,152
|
|
||
21
Medtronic
MDT
$125B
| $73.6M | 1.4% |
766,592
+6,731
|
|
||
22
Relay Therapeutics
RLAY
$1.7B
| $70.6M | 1.34% |
8,345,364
-246
|
|
||
23
Idexx Laboratories
IDXX
$52.4B
| $64M | 1.21% |
94,539
+17,952
|
|
||
24
UnitedHealth
UNH
$267B
| $57.8M | 1.1% |
175,169
+5,112
|
|
||
25
DexCom
DXCM
$28.3B
| $56.2M | 1.07% |
847,405
+61,287
|
|